PMCB vs SNOW · $8.6M cap vs rev $1.55B
PharmaCyte Biotech Inc (PMCB) versus Snowflake Inc. (SNOW) — a side-by-side from cached financials, not a winner call.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Snowflake Inc. (SNOW) is a software - application company listed on US. It is led by Sridhar Ramaswamy.
Latest reported PMCB revenue for 2026-04-30 was $0. Net income was -$19.4M. PMCB currently screens at market cap $8.6M.
Latest reported SNOW revenue for 2026-07-31 was $1.55B. Net income was -$191.7M. Revenue was up 11.2% from 2026-04-30 to 2026-07-31. SNOW currently screens at market cap $73.90B.
PMCB currently screens at market cap $8.6M. SNOW currently screens at market cap $73.90B.
Not investment advice. Open the PMCB and SNOW stock pages for the full models.
Not investment advice.